Ocuphire Pharma
pipeline partnered with indication clinical phase phase phase product eyedrops night vision approved sept | Ocuphire Pharma
Company
Deck Type
Deck date
November 2023
Slide
3 of 42
Similar slides by Ocuphire Pharma
See diffirences between slides (animation)
Investor Presentation
August 2023
pipeline partnered with a is date | Ocuphire Pharma
Related slides by other companies
Oculis
Investor Conference
June 2023
development status | Oculis
23andMe
Investor Presentation
January 2024
next steps | 23andMe
BioAtla
Investor Presentation
August 2022
phase results with support advancing into phase | BioAtla
BioAtla
Investor Presentation
August 2023
phase results with support advancing into phase | BioAtla
Other recent decks by Ocuphire Pharma
See all presentations (10 decks)
Investor Presentation
August 2023
Investor Presentation
May 2023
Results
January 2023
Results
October 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io